$8.70 $0.04 per serving
Product analysis
Melatonin 3 mg offers an inexpensive, focused option that may help adjust sleep timing and shorten the time it takes to fall asleep. Its usefulness depends on when it is taken and the person’s sleep pattern.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The melatonin preparation is not described in detail. That leaves its form quality uncertain and does not establish a particular release pattern.
Ingredient Transparency63
The melatonin amount is clearly listed. Missing preparation details limit comparisons with products that specify how the ingredient is delivered.
Value For Money100
The full serving offers favorable value for melatonin. That makes it an inexpensive option when its sleep-related purpose fits the person’s needs.
Customer Satisfaction92
Customer feedback is strongly positive. A substantial number of ratings provides a broad base of customer feedback.
Product Focus74
One ingredient keeps the formula focused on sleep timing and falling asleep. Broader immune and everyday-health benefits are not established independently of a person’s sleep needs.
- Format
Capsule - Container
- 180 Capsule(s)
- Per serving
- $0.04
- Also available
Melatonin 3 mg$3.62- Customer rating
- 4.7 · 62,679 ratings
Goals
Impact
Highest effect
Melatonin · 3 mg
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Melatonin | 3 mg |
Melatonin · 3 mg OverallScore68
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Melatonin for preventing and treating jet lag.
- Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
- Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
- Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses.
- Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial.
- Exogenous melatonin boosts vaccine-induced immunity in individuals with high pre-existing influenza immunity.
- Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
- Pineal-opioid system interactions in the control of immunoinflammatory responses.
- Influenza vaccine response is predicted by chronotype and differentially associated with pre- and post-vaccination sleep.
- Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.
- Meta-analysis: melatonin for the treatment of primary sleep disorders.
- Melatonin treatment for age-related insomnia.
- The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
- Effects of exogenous melatonin on sleep: a meta-analysis.